Jung, Erik http://orcid.org/0000-0002-5016-8202
Alfonso, Julieta
Osswald, Matthias
Monyer, Hannah http://orcid.org/0000-0002-9332-5749
Wick, Wolfgang http://orcid.org/0000-0002-6171-634X
Winkler, Frank http://orcid.org/0000-0003-4892-6104
Article History
Received: 6 May 2019
Accepted: 17 October 2019
First Online: 12 November 2019
Change Date: 19 November 2019
Change Type: Update
Change Details: When this article was initially published online, the Editorial Summary was missing. It should read: “Malignant gliomas recapitulate steps in neurodevelopment to form organ-like structures. Jung et al. review how neuroscience can provide novel insights into glioma biology, and how these insights might be used for future therapeutic approaches.”
Competing interests
: E.J., F.W., and W.W. report the patent (WO2017020982A1) “Agents for use in the treatment of glioma.” F.W. is co-founder of DC Europa Ltd (a company trading under the name Divide & Conquer), which is developing new medicines for the treatment of glioma. Divide & Conquer also provides research funding to F.W.’s lab under a research collaboration agreement.